Vamsi Kota

2.9k total citations · 1 hit paper
156 papers, 1.4k citations indexed

About

Vamsi Kota is a scholar working on Hematology, Genetics and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Vamsi Kota has authored 156 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 112 papers in Hematology, 50 papers in Genetics and 37 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Vamsi Kota's work include Chronic Myeloid Leukemia Treatments (55 papers), Acute Myeloid Leukemia Research (53 papers) and Acute Lymphoblastic Leukemia research (35 papers). Vamsi Kota is often cited by papers focused on Chronic Myeloid Leukemia Treatments (55 papers), Acute Myeloid Leukemia Research (53 papers) and Acute Lymphoblastic Leukemia research (35 papers). Vamsi Kota collaborates with scholars based in United States, United Kingdom and Italy. Vamsi Kota's co-authors include Ravindra Kolhe, Anand P. Jillella, Ashis K. Mondal, Jörge E. Cortes, Pankaj Ahluwalia, Nikhil Sahajpal, Adam Barsouk, Anusha Vakiti, Prashanth Rawla and Alexander Barsouk and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Vamsi Kota

139 papers receiving 1.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Epidemiology, Staging, and Management of Multiple Myeloma

2021 182 citations Sandeep Padala, Adam Barsouk et al. SHILAP Revista de lepidopterología profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Vamsi Kota United States	19	887	408	397	397	179	156	1.4k
Mieczysław Komarnicki Poland	19	580 0.7×	384 0.9×	483 1.2×	410 1.0×	84 0.5×	97	1.4k
Tariq I. Mughal United States	21	888 1.0×	430 1.1×	463 1.2×	788 2.0×	114 0.6×	115	1.7k
Yeo‐Kyeoung Kim South Korea	20	675 0.8×	261 0.6×	412 1.0×	253 0.6×	132 0.7×	91	1.2k
Guillermo Montalban‐Bravo United States	23	1.5k 1.6×	361 0.9×	766 1.9×	519 1.3×	363 2.0×	202	1.9k
Álvaro Aguayo Mexico	19	867 1.0×	506 1.2×	933 2.4×	501 1.3×	122 0.7×	46	1.8k
Marta Krejčí Czechia	17	832 0.9×	574 1.4×	497 1.3×	190 0.5×	70 0.4×	155	1.3k
Qaiser Bashir United States	22	1.4k 1.6×	745 1.8×	762 1.9×	273 0.7×	273 1.5×	182	2.0k
Mario Tiribelli Italy	25	1.3k 1.4×	610 1.5×	656 1.7×	922 2.3×	277 1.5×	97	2.2k
Musa Yılmaz United States	25	1.5k 1.7×	553 1.4×	689 1.7×	596 1.5×	641 3.6×	149	2.0k
Agnieszka Wierzbowska Poland	22	1.5k 1.6×	483 1.2×	1.1k 2.8×	461 1.2×	435 2.4×	108	2.3k

Countries citing papers authored by Vamsi Kota

Since Specialization

Citations

This map shows the geographic impact of Vamsi Kota's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Vamsi Kota with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Vamsi Kota more than expected).

Fields of papers citing papers by Vamsi Kota

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Vamsi Kota. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Vamsi Kota. The network helps show where Vamsi Kota may publish in the future.

Co-authorship network of co-authors of Vamsi Kota

This figure shows the co-authorship network connecting the top 25 collaborators of Vamsi Kota. A scholar is included among the top collaborators of Vamsi Kota based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Vamsi Kota. Vamsi Kota is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Galvis, Marisol Miranda, et al.. (2025). Estimating the burden of chronic stress through allostatic load in patients with chronic myeloid leukemia. Leukemia. 39(11). 2735–2744.

Abaza, Yasmin, Eric S. Winer, Guru Subramanian Guru Murthy, et al.. (2024). Clinical outcomes of hypomethylating agents plus Venetoclax as frontline treatment in patients 75 years and older with acute myeloid leukemia: Real‐world data from eight US academic centers. American Journal of Hematology. 99(4). 606–614. 12 indexed citations

Wang, Ning, Abdul Salam, Rashmi Pant, et al.. (2024). Blood pressure lowering efficacy of antihypertensive drugs and their combinations: a systematic review and meta-analysis of 500 randomised, double-blind placebo-controlled trials. European Heart Journal. 45(Supplement_1). 1 indexed citations

Ahluwalia, Pankaj, Ashis K. Mondal, Harmanpreet Singh, et al.. (2023). Immune Factors Drive Expression of SARS-CoV-2 Receptor Genes Amid Sexual Disparity. Viruses. 15(3). 657–657. 1 indexed citations

Singh, Rishabh, Michal Kubiak, Mohammad Mian, et al.. (2023). Single center experience of using Anakinra prophylactically at Day 0 to reduce CD19 CART toxicities.. Journal of Clinical Oncology. 41(16_suppl). e19503–e19503.

Corley, Courtney D., Kimberly Green, Locke J. Bryan, et al.. (2023). Bortezomib Induced Peripheral and Severe Autonomic Neuropathy Characterized By Dizziness, Orthostatic Hypotension and Weight Loss. Blood. 142(Supplement 1). 6660–6660.

Chen, Xinyu, et al.. (2023). Hematological Adverse Events with Tyrosine Kinase Inhibitors for Chronic Myeloid Leukemia: A Systematic Review with Meta-Analysis. Cancers. 15(17). 4354–4354. 6 indexed citations

Badar, Talha, Ehab Atallah, Rory M. Shallis, et al.. (2023). Survival of TP53-mutated acute myeloid leukemia patients receiving allogeneic stem cell transplantation after first induction or salvage therapy: results from the Consortium on Myeloid Malignancies and Neoplastic Diseases (COMMAND). Leukemia. 37(4). 799–806. 29 indexed citations

Sahajpal, Nikhil, Ashis K. Mondal, Harmanpreet Singh, et al.. (2023). Optical Genome Mapping: Integrating Structural Variations for Precise Homologous Recombination Deficiency Score Calculation. Genes. 14(9). 1683–1683. 2 indexed citations

10.

Ashaye, Ajibade, Mehul Dalal, Vamsi Kota, et al.. (2022). Patient preferences for frontline therapies for Philadelphia chromosome-positive acute lymphoblastic leukemia: a discrete choice experiment. Future Oncology. 18(17). 2075–2085. 4 indexed citations

11.

Brümmendorf, Tim H., Jörge E. Cortes, Dragana Milojković, et al.. (2022). Bosutinib versus imatinib for newly diagnosed chronic phase chronic myeloid leukemia: final results from the BFORE trial. Leukemia. 36(7). 1825–1833. 79 indexed citations

12.

Badar, Talha, Mark R. Litzow, Rory M. Shallis, et al.. (2022). Disparities in receiving disease‐directed therapy, allogeneic stem cell transplantation in non‐Hispanic Black patients with TP53‐mutated acute myeloid leukemia. Cancer. 129(6). 934–945. 5 indexed citations

13.

Padala, Sandeep, Adam Barsouk, Alexander Barsouk, et al.. (2021). Epidemiology, Staging, and Management of Multiple Myeloma. SHILAP Revista de lepidopterología. 9(1). 3–3. 182 indexed citations breakdown →

14.

Sahajpal, Nikhil, Ashis K. Mondal, Sudha Ananth, et al.. (2020). Proposal of RT-PCR–Based Mass Population Screening for Severe Acute Respiratory Syndrome Coronavirus 2 (Coronavirus Disease 2019). Journal of Molecular Diagnostics. 22(10). 1294–1299. 25 indexed citations

15.

Kolhe, Ravindra, et al.. (2020). Role of Indoleamine 2,3-Dioxygenase in Acute Myeloid Leukemia. Future Oncology. 16(36). 3085–3094. 6 indexed citations

16.

Arellano, Martha, et al.. (2017). Comorbid Conditions in Newly Diagnosed Patients with Acute Promyelocytic Leukemia (APL) in Real World Patients; Decreased Induction Mortality Despite a High Comorbid Index. Blood. 130. 3379–3379. 1 indexed citations

17.

Bell, Jill A., Aaron Galaznik, Eileen Farrelly, et al.. (2017). Treatment Characteristics and Outcomes for Newly Diagnosed Elderly Patients with Acute Myeloid Leukemia (AML) Treated in the United States with Either 7+3 or a Hypomethylating Agent (HMA). Blood. 130. 2167–2167. 2 indexed citations

18.

Kota, Vamsi, et al.. (2017). Weight Gain during Induction Therapy of Acute Promyelocytic Leukemia Patients: A Preventable Problem. Blood. 130. 5017–5017. 2 indexed citations

19.

Arellano, Martha, et al.. (2017). A Normal Prothrombin Time, Activated Partial Thromboplastin Time and Fibrinogen Level Do Not Eliminate Disseminated Intravascular Coagulation (DIC) and Bleeding Risk in Patients with Acute Promyelocytic Leukemia. Blood. 130. 4869–4869. 1 indexed citations

20.

Hao, Zhonglin & Vamsi Kota. (2015). Volasertib for AML: clinical use and patient consideration. OncoTargets and Therapy. 8. 1761–1761. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact